marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Kezar Life Sciences Financial Ratios 2011-2024 | KZR
Annual Financial Ratios Kezar Life Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.6 | -5.1 | -14.3 | -5.8 | -1.5 | -7.6 | - | -0.4 | - | - | - | - | - |
P/S |
8.8 | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.4 | -1.0 | -1.0 | -0.9 | -1.8 | -2.3 | -14.2 | -26.6 | - | - | - | - | - |
EV (Enterprise Value) |
59.8 M | 337 M | 742 M | 231 M | 49.4 M | 158 M | 28.9 M | 22.8 M | - | - | - | - | - |
EBITDA per Share |
-1.52 | -1.04 | -1.01 | -0.94 | -1.89 | -2.34 | - | -0.482 | - | - | - | - | - |
EV/EBITDA |
-13.1 | -6.0 | -1.1 | -6.3 | - | 0.7 | - | - | - | - | - | ||
PEG |
- | -0.34 | 0.08 | -0.05 | - | 0.32 | - | - | - | - | - | ||
P/B |
0.3 | 1.3 | 4.0 | 1.7 | 0.7 | 1.6 | - | 0.3 | - | - | - | - | - |
P/CF |
-0.8 | -5.9 | -18.5 | -6.5 | -1.7 | -8.1 | - | -0.4 | - | - | - | - | - |
ROE % |
-54.31 | -25.29 | -27.75 | -29.61 | -44.96 | -21.29 | - | -83.64 | - | - | - | - | - |
ROA % |
-46.05 | -22.78 | -25.07 | -27.49 | -39.20 | -20.20 | - | -78.69 | - | - | - | - | - |
ROCE % |
-59.40 | -26.37 | -27.76 | -30.47 | -44.72 | -22.21 | - | -83.45 | - | - | - | - | - |
Current Ratio |
6.6 | 10.1 | 10.3 | 14.0 | 13.5 | 32.9 | - | 16.1 | - | - | - | - | - |
DSO |
38.3 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
38.3 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
38.3 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Kezar Life Sciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.78 | -0.3 | -0.3 | - | -3.18 | -0.34 | -0.31 | - | -0.25 | -0.25 | -0.26 | - | -0.28 | -0.25 | -0.25 | -0.22 | -0.23 | -0.22 | -0.3 | -0.5 | -0.48 | -0.46 | -0.4 | -0.3 | -0.3 | -3.31 | -6.53 | -3.34 | -3.31 | -3.3 | -4.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-2.97 | -0.32 | -0.32 | - | -3.47 | -0.37 | -0.34 | - | -0.26 | -0.25 | -0.26 | - | -0.26 | -0.24 | -0.25 | - | -0.21 | -0.21 | -0.31 | - | -0.46 | -0.46 | -0.42 | - | -0.3 | -3.26 | -6.6 | - | -3.28 | -3.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-52.96 | -48.50 | -44.66 | -29.95 | -36.26 | -31.86 | -26.84 | -18.64 | -30.75 | -36.55 | -41.09 | -31.32 | -39.08 | -34.99 | -31.75 | -29.61 | -34.12 | -37.84 | -42.27 | -44.96 | -38.00 | -31.48 | -26.54 | -21.29 | -7.03 | 6.28 | 19.82 | 24.37 | 15.42 | 7.32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-44.50 | -41.38 | -38.64 | -26.31 | -32.16 | -28.75 | -24.62 | -17.32 | -28.37 | -33.56 | -37.74 | -28.86 | -36.06 | -32.45 | -29.43 | -27.49 | -30.99 | -33.77 | -37.25 | -39.20 | -33.54 | -28.26 | -24.42 | -20.20 | -19.40 | -18.30 | -15.86 | -11.55 | -7.30 | -3.47 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-57.73 | -53.17 | -49.19 | -33.06 | -39.75 | -34.61 | -28.57 | -19.01 | -31.14 | -36.59 | -41.12 | -31.43 | -39.62 | -35.68 | -32.65 | -22.61 | -35.02 | -39.23 | -44.23 | -35.04 | -40.79 | -34.15 | -28.55 | -16.82 | -8.29 | 6.00 | 19.72 | 15.86 | 15.86 | 7.32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
5.5 | 6.2 | 6.6 | 6.6 | 7.5 | 8.5 | 9.0 | 10.1 | 14.1 | 15.8 | 12.9 | 10.3 | 11.5 | 14.3 | 13.0 | 14.0 | 14.0 | 14.0 | 14.0 | 7.8 | 7.8 | 7.8 | 7.8 | 19.5 | 19.5 | 19.5 | 19.5 | 27.4 | 27.4 | 27.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency